Abstract:The fibrillation of therapeutic peptides can present significant quality concerns and poses challenges for manufacturing and storage. A fundamental understanding of the mechanisms of fibrillation is critical for the rational design of fibrillation-resistant peptide drugs and can accelerate product development by guiding the selection of solution-stable candidates and formulations. The studies reported here investigated the effects of structural modifications on the fibrillation of a 29-residue peptide (PepA) and two sequence modified variants (PepB, PepC). The C-terminus of PepA was amidated, whereas both PepB and PepC retained the carboxylate, and Ser16 in PepA and PepB was substituted with a helix-stabilizing residue, α-aminoisobutyric acid (Aib), in PepC. In thermal denaturation studies by far-UV CD spectroscopy and fibrillation kinetic studies by fluorescence and turbidity measurements, PepA and PepB showed heat-induced conformational changes and were found to form fibrils, whereas PepC did not fibrillate and showed only minor changes in the CD signal. Pulsed hydrogen-deuterium exchange mass spectrometry (HDX-MS) showed a high degree of protection from HD exchange in mature PepA fibrils and its proteolytic fragments, indicating that most of the sequence had been incorporated into the fibril structure and occurred nearly simultaneously throughout the sequence. The effects of the net peptide charge and formulation pH on fibrillation kinetics were investigated. In real-time stability studies of two formulations of PepA at pH's 7.4 and 8.0, analytical methods detected significant changes in the stability of the formulations at different time points during the study, which were not observed during accelerated studies. Additionally, PepA samples were withdrawn from real-time stability and subjected to additional stress (40 °C, continuous shaking) to induce fibrillation; an approach that successfully amplified oligomers or prefibrillar species previously undetected in a thioflavin T assay. Taken together, these studies present an approach to differentiate and characterize fibrillation risk in structurally related peptides under accelerated and real-time conditions, providing a model for rapid, iterative structural design to optimize the stability of therapeutic peptides.

Experimental procedures to investigate fibrillation of proteins

Experimental techniques for detecting and evaluating the amyloid fibrils

Monitoring and Inhibition of Insulin Fibrillation by a Small Organic Fluorogen with Aggregation-Induced Emission Characteristics.

Techniques for monitoring protein misfolding and aggregation in vitro and in living cells

Inhibiting amyloid-like aggregation through bio-conjugation of proteins with polymer surfactant

Recent Advances In Analysis Of Protein Aggregation In Biopharmaceuticals

On the Protein Fibrillation Pathway: Oligomer Intermediates Detection Using ATR-FTIR Spectroscopy

A Model Study to Assess Fibrillation and Product Stability to Support Peptide Drug Design

Direct Monitoring of Heat-Stressed Biopolymers with Temperature-Controlled Electrospray Ionization Mass Spectrometry.

Changes in Interfacial and Emulsifying Properties of β-Lactoglobulin Protein during Its Fibrillation

Process, Outcomes and Possible Elimination of Aggregation with Special Reference to Heme Proteins; Likely Remediations of Proteinopathies

Early Events in Insulin Fibrillization Studied by Time-Lapse Atomic Force Microscopy

The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage

Protein aggregation kinetics during Protein A chromatography. Case study for an Fc fusion protein

A new fibrillization mechanism of β-lactoglobulin in glycine solutions

Nucleation Of Protein Fibrillation By Nanoparticles

Insights into Protein Unfolding under pH, Temperature, and Shear using Molecular Dynamics Simulations

Sheet-like and tubular aggregates of protein nanofibril-phosphate hybrids.

Fibrillization Kinetics and Rheological Properties of Panda Bean (vigna Umbellata (thunb.) Ohwi Et Ohashi) Protein Isolate at Ph 2.0.

Study on the properties of amyloid fibrils in kidney bean protein solution and gelation

Fibrillation of Human Serum Albumin Differentially Affected by Asp-, Arg-, and Tyr-Capped Gold Nanoparticles